ADAR1 Capital Management »

NCR Atleos Corp shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of NCR Atleos Corp (NATL) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in NCR Atleos Corp

Tip: Access up to 7 years of quarterly data

All positions including NCR Atleos Corp held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in NCR Atleos Corp by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $20k 1.0k 19.75
2023-12-31 $24k 1.0k 24.29

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding NCR Atleos Corp

BlackRock
BlackRock
Vanguard Group
Alliancebernstein
Engaged Capital
State Street Corporation
Brown Advisory Holdings Incorporated
Victory Capital Management
Hanna Zanoni
First Pacific Advisors
Engine Capital Management
Dimensional Fund Advisors
Geode Capital Management
LSV Asset Management
Morgan Stanley

View all funds holding NCR Atleos Corp